Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youngjun Yoo

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMC Medical Genomics|June 6, 2015
Graph pyramids for protein function predictionTushar Sandhan, Youngjun Yoo, Jin Choi, et al.
Journal of Clinical Pharmacology|September 6, 2025
Population Pharmacokinetics of Valemetostat and Exposure-Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T-Cell LymphomaHiroyuki Inoue, Xiaoning Wang, Ramon Garcia, et al.
Journal of Clinical Pharmacology|December 28, 2025
Response to Comment on "Population Pharmacokinetics of Valemetostat and Exposure-Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma"Hiroyuki Inoue, Xiaoning Wang, Ramon Garcia, et al.
Clinical and Translational Science|June 5, 2026
The Effect of Efavirenz and Rufinamide on the Pharmacokinetics and Safety of Quizartinib: Two Phase 1 Studies in Healthy ParticipantsYoungJun Yoo, Hamim Zahir, Shinichi Inaba, et al.
The Journal of Physical Chemistry. B|December 14, 2016
Enhanced Polarization Ratio of Electrospun Nanofibers with Increased Intrachain Order by Postsolvent TreatmentsSangcheol Yoon, Siyoung Ji, Youngjun Yoo, et al.
Journal of the Pediatric Infectious Diseases Society|January 25, 2021
Prolonged Post-Discontinuation Antibiotic Exposure in Very Low Birth Weight Neonates at Risk for Early-Onset SepsisJennifer Le, Rachel G Greenberg, Daniel K Benjamin, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|February 25, 2022
Ampicillin dosing in premature infants for early-onset sepsis: exposure-driven efficacy, safety, and stewardshipJennifer Le, Rachel G Greenberg, YoungJun Yoo, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMC Medical Genomics|June 6, 2015
Graph pyramids for protein function predictionTushar Sandhan, Youngjun Yoo, Jin Choi, et al.
Journal of Clinical Pharmacology|September 6, 2025
Population Pharmacokinetics of Valemetostat and Exposure-Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T-Cell LymphomaHiroyuki Inoue, Xiaoning Wang, Ramon Garcia, et al.
Journal of Clinical Pharmacology|December 28, 2025
Response to Comment on "Population Pharmacokinetics of Valemetostat and Exposure-Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma"Hiroyuki Inoue, Xiaoning Wang, Ramon Garcia, et al.
Clinical and Translational Science|June 5, 2026
The Effect of Efavirenz and Rufinamide on the Pharmacokinetics and Safety of Quizartinib: Two Phase 1 Studies in Healthy ParticipantsYoungJun Yoo, Hamim Zahir, Shinichi Inaba, et al.
The Journal of Physical Chemistry. B|December 14, 2016
Enhanced Polarization Ratio of Electrospun Nanofibers with Increased Intrachain Order by Postsolvent TreatmentsSangcheol Yoon, Siyoung Ji, Youngjun Yoo, et al.
Journal of the Pediatric Infectious Diseases Society|January 25, 2021
Prolonged Post-Discontinuation Antibiotic Exposure in Very Low Birth Weight Neonates at Risk for Early-Onset SepsisJennifer Le, Rachel G Greenberg, Daniel K Benjamin, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|February 25, 2022
Ampicillin dosing in premature infants for early-onset sepsis: exposure-driven efficacy, safety, and stewardshipJennifer Le, Rachel G Greenberg, YoungJun Yoo, et al.
Pageof 1